Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera ® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region
Condition: Relapsing Remitting Multiple Sclerosis Intervention: Drug: Dimethyl Fumarate (DMF) Sponsor: Hikma Pharmaceuticals LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials